Stay updated on Pembrolizumab in MSI Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in MSI Tumors Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check17 days agoChange DetectedA banner announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a transition following Executive Order 14434.SummaryDifference0.6%

- Check24 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check38 days agoChange DetectedThe ClinicalTrials.gov study record page appears unchanged, with the same study information and controls visible.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry v3.7.0 was added to the record history, replacing the previous v3.6.6 entry. This reflects a metadata update to the page rather than changes to study content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in MSI Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MSI Tumors Clinical Trial page.